F 18 T807 Tau PET Imaging of Older (≥ 50 Years Old) HIV Infected (HIV+) and HIV Uninfected (HIV-) Individuals

Trial Profile

F 18 T807 Tau PET Imaging of Older (≥ 50 Years Old) HIV Infected (HIV+) and HIV Uninfected (HIV-) Individuals

Recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Sep 2017

At a glance

  • Drugs Flortaucipir F 18 (Primary)
  • Indications Neurodegenerative disorders
  • Focus Diagnostic use
  • Most Recent Events

    • 14 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top